EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Borregaard ASA (0QB7) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Borregaard ASA NOK 89.38, price NOK 152, upside -41.3%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · GB · ISIN NO0010657505

BA Broad data Sep 24, 2026

Borregaard ASA

0QB7 · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value kr 89.38 · Strongly overvalued (−41.3%)
✓Quality 62/100
!Mixed Growth (revenue 3y +6.7 %/yr)
!Thin margins · 2.2% net margin (TTM)
✓Low debt
·3.1% dividend yield · Safety not assessed
!Moderate moat 45/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 208.50 kr 113.87 Fair Value kr 89.38 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range kr 113.87 – kr 208.50 · fair‑value band kr 53.32 – kr 112.31 · the kr 152.20 price screens above the kr 89.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals.

Show more

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

Stock analysis

Borregaard ASA (0QB7) currently trades at kr 152.20, while our model-based Fair Value estimate is kr 89.38, 41.3% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of kr 86.50 per share, and 0 of the 25 models we run sit above the kr 152.20 price.

Bear case: the Asset-Based group reads lowest at kr 20.80, and 25 of the 25 models stay below the price. Evidence for this calculation is high.

Scenario range: kr 53.32 (bear) to kr 112.31 (bull), the price of kr 152.20 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Borregaard ASA reported revenue of 5.8B NOK in FY2021 versus 4.6B NOK in FY2017, a compound +5.9%/yr. Reported net income was 692M NOK in FY2021, compounding +5.2%/yr from FY2017.

Key figures

Market cap 20.7B NOK (≈ $2.2B) · P/S ratio 2.67 · Dividend yield 3.1% · Net margin 11.9% · Return on equity 2.8% · Return on assets (EBIT) 10.6% · Operating margin 15.9% · Revenue (TTM) 7.8B NOK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 22% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −41%, 0QB7 screens richer than that median.

Fair Value models

Bear kr 53.32 Fair Value kr 89.38 Bull kr 112.31
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF kr 49.27 kr 79.21 kr 122.85 75
EPV kr 36.99 kr 44.22 kr 50.46 74
Growth DCF kr 50.12 kr 76.55 kr 112.73 74
All 25 models by family
DCF Models
FCF DCF kr 49.27 kr 79.21 kr 122.85 75
5Y Revenue Exit kr 39.43 kr 65.32 kr 97.90 68
5Y EBITDA Exit kr 55.49 kr 95.26 kr 141.33 71
5Y P/E Exit kr 48.96 kr 83.08 kr 118.57 67
10Y Revenue Exit kr 41.26 kr 65.36 kr 96.92 63
10Y EBITDA Exit kr 52.56 kr 85.64 kr 129.21 64
10Y P/E Exit kr 48.49 kr 77.39 kr 112.28 60
Earnings-Based
Graham-Dodd kr 34.60 kr 105.77 kr 140.41 62
Lynch FV kr 22.72 kr 32.46 kr 42.20 58
PEG = 1.0 kr 22.72 kr 32.46 kr 42.20 55
EPV kr 36.99 kr 44.22 kr 50.46 74
Dividend Discount
Gordon GGM kr 17.69 kr 35.26 kr 53.39 64
DDM Multi-Stage kr 17.69 kr 28.52 kr 37.22 64
Multiples
P/E Multiple kr 64.87 kr 86.50 kr 108.12 63
P/S Multiple kr 48.02 kr 64.02 kr 80.03 58
P/B Multiple kr 64.87 kr 86.50 kr 108.12 55
EV/EBIT kr 64.70 kr 89.20 kr 113.70 66
EV/EBITDA kr 67.64 kr 93.11 kr 118.59 67
EV/Revenue kr 36.02 kr 55.23 kr 74.44 53
Asset-Based
NCAV (Graham) kr 15.52 kr 20.80 kr 31.04 54
Growth DCF
Growth DCF kr 50.12 kr 76.55 kr 112.73 74
Rev-Margin DCF kr 39.43 kr 65.70 kr 95.87 69
Economic Profit
Residual Income kr 32.14 kr 40.66 kr 59.78 72
ROIC Compounder kr 38.35 kr 50.09 kr 64.34 69
Growth Earnings
Growth-Adj P/E kr 54.61 kr 78.01 kr 101.42 65

Open the full fair value analysis →

Notify me when 0QB7 reaches fair value

Put 0QB7 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 62/100

Of which business quality 62 · Market factors (momentum, volatility) 44

Profitability 62
Margins and returns on capital today
Quality Growth 60
Are margins and returns improving?
Cashflow 63
Earnings quality: real cash, not paper profit
Fin. Strength 57
Balance sheet, leverage, solvency risk
Investment 72
Disciplined investing over empire-building
Low Volatility 88
Calm price path (market factor)
Momentum 30
Price trend over the last 3–12 months (market factor)
52W Momentum 19
Distance to the 52-week high (market factor)

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 65/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+9.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
15.9% (2017) → 16.4% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
not computed

0QB7 screens overvalued: fair value 41% below the price. Compare with Linde plc →

Compare Borregaard ASA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $474.65 $441.72 −7%
The Sherwin-Williams Company SHW $330.44 $151.68 −54%
Ecolab Inc ECL $274.58 $96.56 −65%
Air Products and Chemicals, Inc APD $279.19 $121.30 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 234.23 TWD −2%
Givaudan SA GIVN CHF 3,360 CHF 1,527 −55%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%
PPG Industries, Inc PPG $104.67 $76.98 −26%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Borregaard ASA Fair Value". https://www.fairvalue-calculator.com/stock/0QB7

Frequently asked questions

Is Borregaard ASA (0QB7) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of kr 89.38 versus a price of kr 152.20, about −41% upside (overvalued).
What is the fair value of 0QB7?
Our model-based fair value for Borregaard ASA is kr 89.38 (as of Sep 24, 2026), built from audited fundamentals. The current price: kr 152.20.
What is the quality score of 0QB7?
Borregaard ASA has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Borregaard ASA (0QB7)?
Our model-based price target is the fair value of kr 89.38 (as of Sep 24, 2026) from 25 valuation models. Cautious scenario kr 53.32, optimistic scenario kr 112.31. It is a calculation from audited fundamentals, not an analyst target.
What is the Borregaard ASA stock forecast for 2026?
Our models put fair value at kr 89.38, about −41% upside versus a price of kr 152.20 (overvalued). Cautious scenario kr 53.32, optimistic scenario kr 112.31. The calculation is refreshed regularly with new filings.
What is the revenue of Borregaard ASA (0QB7)?
Borregaard ASA reported trailing-twelve-month revenue of about 7.8B NOK (latest available figure, as of Sep 24, 2026).
Does Borregaard ASA pay a dividend?
Borregaard ASA currently shows a dividend yield of about 3.12% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Borregaard ASA (0QB7)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Borregaard ASA it is kr 89.38 per share (as of Sep 24, 2026), against a price of kr 152.20. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Borregaard ASA stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0QB7 trades above its calculated fair value: price kr 152.20, fair value kr 89.38, a gap of about −41% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0QB7?
No. The price is what the market pays today (kr 152.20); the fair value is what the company's own numbers justify (kr 89.38). For Borregaard ASA the two are kr 62.82 per share apart. That gap is exactly why we show both numbers side by side.
How much is Borregaard ASA worth?
The market values Borregaard ASA at about 20.7B NOK (market capitalisation, as of Sep 24, 2026). Per share that is kr 152.20; our models calculate a fair value of kr 89.38 per share.
What do the bullish and bearish scenarios say about 0QB7?
Our models span a range for Borregaard ASA: cautious scenario kr 53.32, base kr 89.38, optimistic kr 112.31 per share (as of Sep 24, 2026, price kr 152.20). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 0QB7 from its 52-week high?
Borregaard ASA trades at kr 152.20, about 22% below its 52-week high of kr 194.66 and 10% above the low of kr 137.80 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 89.38 is for.
Which stocks are comparable to Borregaard ASA?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Borregaard ASA stock attractive at the current price?
The data as of Sep 24, 2026: price kr 152.20, calculated fair value kr 89.38 (−41%), Quality Score 62/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0QB7 calculated?
We run Borregaard ASA through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 89.38, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Borregaard ASA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Borregaard ASA (0QB7)?
The closing price on Oct 2, 2026 was kr 152.20. Our model-based fair value is kr 89.38, about −41% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Borregaard ASA right now?
The price sits above even our optimistic bull case (kr 112.31). The favourable scenario is already priced in. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 53.32 to kr 112.31) leaves room in how you read the outcome.

Key figures of Borregaard ASA

How large is the market capitalisation of Borregaard ASA (0QB7)?
The market capitalisation of Borregaard ASA is 20.7B NOK (≈ $2.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Borregaard ASA (0QB7)?
The price-to-sales ratio of Borregaard ASA is 2.67 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Borregaard ASA (0QB7)?
The dividend yield of Borregaard ASA is 3.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Borregaard ASA (0QB7)?
The net margin of Borregaard ASA is 11.9% (fiscal year 2021). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Borregaard ASA (0QB7)?
The return on equity (ROE) of Borregaard ASA is 2.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Borregaard ASA (0QB7)?
On an EBIT basis the return on assets of Borregaard ASA is 10.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Borregaard ASA (0QB7)?
The operating margin of Borregaard ASA is 15.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Borregaard ASA (0QB7)?
Revenue at Borregaard ASA is growing +3.4% versus a year earlier (3y avg +6.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Borregaard ASA (0QB7)?
Earnings per share at Borregaard ASA are growing −27.8% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.